Adam Kahleifeh, PharmD, BCOP
Articles by Adam Kahleifeh, PharmD, BCOP

Advanced Approaches to Pediatric Fluid and Electrolyte Therapy: What Pharmacists Need to Know
ByErica Tonti, PharmD, BCPPS,Natalie Brumwell, PharmD, BCOP,Jacqueline Dela Pena, PharmD, BCOP,Melinda Cook, PharmD, BCOP,Alice Wang, PharmD, BCOP,Adam Kahleifeh, PharmD, BCOP Fluid therapy in pediatrics involves a systematic approach distinguishing maintenance, deficit, and replacement fluids to effectively manage hydration and electrolyte balance.

Updates in the Treatment of H. Pylori Infection
ByAdam Kahleifeh, PharmD, BCOP,Erica Tonti, PharmD, BCPPS,Natalie Brumwell, PharmD, BCOP,Jacqueline Dela Pena, PharmD, BCOP,Melinda Cook, PharmD, BCOP,Alice Wang, PharmD, BCOP H. pylori requires diagnosis, antibiotic- and acid-suppression-based therapy, and post-treatment eradication confirmation to prevent gastritis and cancer.

Current Pneumococcal Vaccination Recommendations: A Clinical Update
ByAlice Wang, PharmD, BCOP,Natalie Brumwell, PharmD, BCOP,Jacqueline Dela Pena, PharmD, BCOP,Melinda Cook, PharmD, BCOP,Adam Kahleifeh, PharmD, BCOP,Erica Tonti, PharmD, BCPPS 
BTK Inhibitors with CAR T-cell Therapy
ByNatalie Brumwell, PharmD, BCOP,Jacqueline Dela Pena, PharmD, BCOP,Melinda Cook, PharmD, BCOP,Alice Wang, PharmD, BCOP,Adam Kahleifeh, PharmD, BCOP,Erica Tonti, PharmD, BCPPS,Charlene Kabel, PharmD, BCOP Explore how combining BTK inhibitors with CAR T-cell therapy enhances treatment efficacy for B-cell malignancies while managing potential toxicities.

Adam Kahleifeh, PharmD, BCOP, discusses the impact of IDH mutations in low-grade gliomas.